Kevin Caliendo
Stock Analyst at UBS
(4.26)
# 413
Out of 5,182 analysts
209
Total ratings
65.74%
Success rate
10.19%
Average return
Main Sectors:
Stocks Rated by Kevin Caliendo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DGX Quest Diagnostics | Maintains: Neutral | $210 → $220 | $195.05 | +12.79% | 18 | Apr 22, 2026 | |
| MCK McKesson | Maintains: Buy | $1,012 → $1,000 | $835.00 | +19.76% | 18 | Apr 22, 2026 | |
| EVH Evolent Health | Maintains: Buy | $10 → $5 | $3.62 | +38.12% | 4 | Feb 26, 2026 | |
| MDLN Medline | Maintains: Buy | $48 → $57 | $44.24 | +28.84% | 2 | Feb 26, 2026 | |
| LFST LifeStance Health Group | Maintains: Buy | $10 → $12 | $7.67 | +56.45% | 7 | Feb 26, 2026 | |
| HSIC Henry Schein | Maintains: Neutral | $79 → $87 | $76.12 | +14.29% | 7 | Feb 25, 2026 | |
| ALGN Align Technology | Maintains: Neutral | $175 → $185 | $177.28 | +4.35% | 20 | Feb 5, 2026 | |
| XRAY DENTSPLY SIRONA | Maintains: Buy | $17 → $16 | $11.78 | +35.82% | 13 | Feb 3, 2026 | |
| NVST Envista Holdings | Maintains: Neutral | $22 → $25 | $26.49 | -5.62% | 5 | Feb 3, 2026 | |
| ALHC Alignment Healthcare | Maintains: Neutral | $18 → $21 | $21.90 | -4.11% | 9 | Jan 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $96 → $97 | $80.98 | +19.78% | 11 | Dec 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $77 → $79 | $67.51 | +17.02% | 2 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $380 → $415 | $311.99 | +33.02% | 4 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $4.25 → $4 | $2.32 | +72.41% | 8 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $185 → $220 | $205.61 | +7.00% | 18 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $378 → $430 | $366.77 | +17.24% | 13 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $325 → $320 | $259.57 | +23.28% | 7 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $180 → $170 | $185.46 | -8.34% | 5 | Oct 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $9 | $6.25 | +44.00% | 3 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $410 → $390 | $284.92 | +36.88% | 11 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $380 → $250 | $229.72 | +8.83% | 6 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $72 → $79 | $49.57 | +59.37% | 2 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $610 → $575 | $362.74 | +58.52% | 1 | Jul 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $185 → $180 | $227.79 | -20.98% | 7 | Jul 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $130 → $72 | $6.00 | +1,100.00% | 4 | Mar 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $15 → $11 | $31.62 | -65.21% | 4 | May 4, 2021 |
Quest Diagnostics
Apr 22, 2026
Maintains: Neutral
Price Target: $210 → $220
Current: $195.05
Upside: +12.79%
McKesson
Apr 22, 2026
Maintains: Buy
Price Target: $1,012 → $1,000
Current: $835.00
Upside: +19.76%
Evolent Health
Feb 26, 2026
Maintains: Buy
Price Target: $10 → $5
Current: $3.62
Upside: +38.12%
Medline
Feb 26, 2026
Maintains: Buy
Price Target: $48 → $57
Current: $44.24
Upside: +28.84%
LifeStance Health Group
Feb 26, 2026
Maintains: Buy
Price Target: $10 → $12
Current: $7.67
Upside: +56.45%
Henry Schein
Feb 25, 2026
Maintains: Neutral
Price Target: $79 → $87
Current: $76.12
Upside: +14.29%
Align Technology
Feb 5, 2026
Maintains: Neutral
Price Target: $175 → $185
Current: $177.28
Upside: +4.35%
DENTSPLY SIRONA
Feb 3, 2026
Maintains: Buy
Price Target: $17 → $16
Current: $11.78
Upside: +35.82%
Envista Holdings
Feb 3, 2026
Maintains: Neutral
Price Target: $22 → $25
Current: $26.49
Upside: -5.62%
Alignment Healthcare
Jan 14, 2026
Maintains: Neutral
Price Target: $18 → $21
Current: $21.90
Upside: -4.11%
Dec 10, 2025
Maintains: Buy
Price Target: $96 → $97
Current: $80.98
Upside: +19.78%
Nov 10, 2025
Maintains: Neutral
Price Target: $77 → $79
Current: $67.51
Upside: +17.02%
Nov 7, 2025
Maintains: Buy
Price Target: $380 → $415
Current: $311.99
Upside: +33.02%
Nov 6, 2025
Maintains: Neutral
Price Target: $4.25 → $4
Current: $2.32
Upside: +72.41%
Oct 31, 2025
Maintains: Buy
Price Target: $185 → $220
Current: $205.61
Upside: +7.00%
Oct 29, 2025
Maintains: Buy
Price Target: $378 → $430
Current: $366.77
Upside: +17.24%
Oct 29, 2025
Maintains: Buy
Price Target: $325 → $320
Current: $259.57
Upside: +23.28%
Oct 24, 2025
Maintains: Neutral
Price Target: $180 → $170
Current: $185.46
Upside: -8.34%
May 8, 2025
Maintains: Neutral
Price Target: $12 → $9
Current: $6.25
Upside: +44.00%
Feb 3, 2025
Maintains: Buy
Price Target: $410 → $390
Current: $284.92
Upside: +36.88%
Oct 4, 2024
Maintains: Neutral
Price Target: $380 → $250
Current: $229.72
Upside: +8.83%
Dec 21, 2023
Maintains: Neutral
Price Target: $72 → $79
Current: $49.57
Upside: +59.37%
Jul 13, 2023
Maintains: Buy
Price Target: $610 → $575
Current: $362.74
Upside: +58.52%
Jul 21, 2022
Maintains: Neutral
Price Target: $185 → $180
Current: $227.79
Upside: -20.98%
Mar 8, 2022
Maintains: Neutral
Price Target: $130 → $72
Current: $6.00
Upside: +1,100.00%
May 4, 2021
Downgrades: Neutral
Price Target: $15 → $11
Current: $31.62
Upside: -65.21%